Prognostic value of spleen tyrosine kinase in human solid tumors
Beibei Ni,1,2 Shi Li,1,2 Yang Liu,1,2 Yuqian Huang,1,2 Zesong Li1,2 1Guangdong Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital, Shenzhen, Guangdong, People’s Republ...
Main Authors: | Ni B, Li S, Liu Y, Huang Y, Li Z |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-06-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/prognostic-value-of-spleen-tyrosine-kinase-in-human-solid-tumors-peer-reviewed-article-OTT |
Similar Items
-
Spleen Tyrosine Kinase Is a Critical Regulator of Neutrophil Responses to Candida Species
by: Paige E. Negoro, et al.
Published: (2020-05-01) -
Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020)
by: Liling Huang, et al.
Published: (2020-10-01) -
Spleen Tyrosine Kinase Inhibition Ameliorates Tubular Inflammation in IgA Nephropathy
by: Wai Han Yiu, et al.
Published: (2021-03-01) -
Systematic analysis of spleen tyrosine kinase expression and its clinical outcomes in various cancers
by: Akram I Alwithenani, et al.
Published: (2020-01-01) -
Pursuing Precision: Receptor Tyrosine Kinase Inhibitors for Treatment of Pediatric Solid Tumors
by: Andrew J. Bellantoni, et al.
Published: (2021-07-01)